ArticleProceedings of the National Academy of Sciences of the United States of America2025

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis.

Laila M Rad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.